Immunohistochemical analyses have demonstrated that the levels of key modifying enzymes and histone methylation marks, such as LSD1 and enhancer of zeste homolog 2 (EZH2), are elevated in normal tissues compared with non‐CRC tissues. Here, EZH2 is linked to colorectal carcinoma.